CDT Equity (CDT) Interest & Investment Income (2022 - 2025)
CDT Equity's (CDT) quarterly Interest & Investment Income came in at $9000.0 in Q4 2025, up 350.0% YoY from $2000.0 in Q4 2024, and up 28.57% on a QoQ basis from $7000.0 in Q3 2025.
CDT Equity (CDT) Interest & Investment Income (2022 - 2025) Analysis & Trends
CDT Equity (CDT) has 4 years of Interest & Investment Income data on file, last reported at $9000.0 in Q4 2025.
- Quarterly Interest & Investment Income rose 350.0% year-over-year to $9000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28000.0 (up 115.38% YoY) and the FY2025 annual result came in at $28000.0, up 115.38% from the prior year.
- Interest & Investment Income rose to $9000.0 in Q4 2025, from $7000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.2 million in Q4 2022 to a low of $2000.0 in Q2 2024.
- A 4-year average of $227438.8 and a median of $9000.0 in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 6423.59% — and 2024, when it slumped 99.27%.
- Tracing CDT's Interest & Investment Income over 4 years: stood at $1.2 million in 2022, then slumped by 76.36% to $275290.0 in 2023, then tumbled by 99.27% to $2000.0 in 2024, then surged by 350.0% to $9000.0 in 2025.
- The last three Interest & Investment Income figures came in at $9000.0 (Q4 2025), $7000.0 (Q3 2025), and $4000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - | -17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Jun 30, 2023 | 275,290.00 |
| Mar 31, 2023 | 664,232.00 |
| Dec 31, 2022 | 1.16 Mn |
| Sep 30, 2022 | 609,920.00 |
| Jun 30, 2022 | 191,585.00 |
| Mar 31, 2022 | 10,182.00 |